|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1996-12-12
|
|
pubmed:abstractText |
The mechanism of disease modifying antirheumatic drugs (DMARD) is incompletely understood. We investigated in vitro the effect of DMARD such as bucillamine (Buc), salazosulfapyridine (SASP), and D-penicillamine (D-Pen) on the proliferation of human synovial cells in patients with rheumatoid arthritis (RA).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
65-70
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8838510-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:8838510-Antirheumatic Agents,
pubmed-meshheading:8838510-Base Sequence,
pubmed-meshheading:8838510-Cell Division,
pubmed-meshheading:8838510-Cells, Cultured,
pubmed-meshheading:8838510-Cysteine,
pubmed-meshheading:8838510-Drug Combinations,
pubmed-meshheading:8838510-Humans,
pubmed-meshheading:8838510-Interleukins,
pubmed-meshheading:8838510-Models, Biological,
pubmed-meshheading:8838510-Molecular Sequence Data,
pubmed-meshheading:8838510-Sulfasalazine,
pubmed-meshheading:8838510-Synovial Membrane
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Direct suppression of human synovial cell proliferation in vitro by salazosulfapyridine and bucillamine.
|
|
pubmed:affiliation |
Division of Rheumatology and Immunology, St. Marianna University School of Medicine, Kawasaki, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
